Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

[Recommendations for the prevention and management of tuberculosis in patients treated with tumor necrosis factor alpha inhibitors: a consensus of lithuanian pulmonologists and rheumatologists].

Malakauskas K, Zablockis R, Venalis A, Butrimienė I, Baranauskaitė A, Nargėla RV, Sakalauskas R.

Medicina (Kaunas). 2011;47(3):187-91. Lithuanian.

2.

[Causes and risk factors of pleural empyema and complicated parapneumonic pleural effusion].

Zablockis R, Petruskeviciene R, Nargela RV.

Medicina (Kaunas). 2010;46(2):113-9. Lithuanian.

3.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

4.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
5.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

6.

[Bronchial obstruction evaluation according to different methods].

Nargela RV, Andziulis A.

Medicina (Kaunas). 2003;39(6):550-4. Lithuanian.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk